Nellcor™ pulse oximetry monitors are designed to meet your CCHD screening needs. Medtronic is the only company to receive FDA clearance for a motion-tolerant bedside pulse oximeter portfolio that is also compliant with ISO 80601-2-61 (International Organization for Standardization) standards for pulse oximetry.
A published study revealed an artifact in Masimo pulse oximeters, that increased saturation values of 87-90% by an additional 2%. In CCHD screening, an increase from 89% to 91% could mask some cases of CCHD, resulting in false negative screens with the Masimo pulse oximeters.([FOOTNOTE=Johnston ED, Boyle B, Juszczak E, King A, Brocklehurst P, Stenson BJ. Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter. Arch Dis Child Fetal Neonatal Ed. 2011;96(6):F429-33.],[ANCHOR=],[LINK=])